Encompass Health Corporation Payments for Software
Encompass Health Corporation (EHC) reported Payments for Software of $9.20 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-27.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForSoftware · last filed 2023-02-27
- Encompass Health Corporation payments for software for the quarter ending 2022-12-31 was $1.70M, a 37.04% decline year-over-year.
- Encompass Health Corporation payments for software for the quarter ending 2022-09-30 was $2.60M, a 36.84% increase year-over-year.
- Encompass Health Corporation payments for software for the quarter ending 2021-12-31 was $2.70M, a 3.85% increase year-over-year.
- Encompass Health Corporation payments for software for the quarter ending 2021-09-30 was $1.90M, a 46.15% increase year-over-year.
- Encompass Health Corporation payments for software for fiscal 2022 was $9.20M, a 36.99% decline from fiscal 2021.
- Encompass Health Corporation payments for software for fiscal 2021 was $14.60M, a 75.90% increase from fiscal 2020.
- Encompass Health Corporation payments for software for fiscal 2020 was $8.30M, a 36.15% decline from fiscal 2019.
- Encompass Health Corporation payments for software for fiscal 2019 was $13.00M, a 18.75% decline from fiscal 2018.
| Period end | Payments for Software 3 month | Payments for Software 6 month | Payments for Software 9 month | Payments for Software 9 month as first filed | Payments for Software 12 month | Payments for Software 12 month as first filed |
|---|---|---|---|---|---|---|
| 2022-12-31 | $1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $4.30M derived: sum of 2 quarters · filed 2023-02-27 | $9.20M 10-K · filed 2023-02-27 | |||
| 2022-09-30 | $2.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $7.50M 10-Q · filed 2022-11-02 | ||||
| 2022-06-30 | $4.90M 10-Q · filed 2022-08-04 | |||||
| 2021-12-31 | $2.70M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $4.60M derived: sum of 2 quarters · filed 2023-02-27 | $14.60M 10-K · filed 2023-02-27 | $15.80M 10-K · filed 2022-02-25 | ||
| 2021-09-30 | $1.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $11.90M 10-Q · filed 2022-11-02 | $13.00M 10-Q · filed 2021-11-02 | |||
| 2021-06-30 | $10.00M 10-Q · filed 2022-08-04 | |||||
| 2020-12-31 | $2.60M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $3.90M derived: sum of 2 quarters · filed 2023-02-27 | $8.30M 10-K · filed 2023-02-27 | $8.70M 10-K · filed 2021-02-26 | ||
| 2020-09-30 | $1.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $5.70M 10-Q · filed 2021-11-02 | ||||
| 2020-06-30 | $4.40M 10-Q · filed 2021-08-03 | |||||
| 2019-12-31 | $3.80M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $6.40M derived: sum of 2 quarters · filed 2022-02-25 | $13.00M 10-K · filed 2022-02-25 | |||
| 2019-09-30 | $2.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | $9.20M 10-Q · filed 2020-11-02 | ||||
| 2019-06-30 | $6.60M 10-Q · filed 2020-07-31 | |||||
| 2018-12-31 | $2.80M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $6.30M derived: sum of 2 quarters · filed 2021-02-26 | $16.00M 10-K · filed 2021-02-26 | |||
| 2018-09-30 | $3.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $13.20M 10-Q · filed 2019-10-31 | ||||
| 2018-06-30 | $9.70M 10-Q · filed 2019-07-31 | |||||
| 2017-12-31 | $4.60M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $9.50M derived: sum of 2 quarters · filed 2020-02-27 | $15.60M derived: sum of 3 quarters · filed 2020-02-27 | $19.20M 10-K · filed 2020-02-27 | ||
| 2017-09-30 | $4.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | $11.00M derived: sum of 2 quarters · filed 2018-10-31 | $14.60M 10-Q · filed 2018-10-31 | $22.30M derived: sum of 4 quarters · filed 2019-02-27 | ||
| 2017-06-30 | $6.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $9.70M 10-Q · filed 2018-08-02 | $17.40M derived: sum of 3 quarters · filed 2019-02-27 | $19.70M derived: sum of 4 quarters · filed 2019-02-27 | ||
| 2017-03-31 | $3.60M 10-Q · filed 2017-04-28 | $11.30M derived: sum of 2 quarters · filed 2019-02-27 | $13.60M derived: sum of 3 quarters · filed 2019-02-27 | $21.10M derived: sum of 4 quarters · filed 2019-02-27 | ||
| 2016-12-31 | $7.70M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $10.00M derived: sum of 2 quarters · filed 2019-02-27 | $17.50M derived: sum of 3 quarters · filed 2019-02-27 | $25.20M 10-K · filed 2019-02-27 | ||
| 2016-09-30 | $2.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | $9.80M derived: sum of 2 quarters · filed 2017-10-31 | $17.50M 10-Q · filed 2017-10-31 | $24.90M derived: sum of 4 quarters · filed 2018-02-28 | ||
| 2016-06-30 | $7.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $15.20M 10-Q · filed 2017-08-02 | $22.60M derived: sum of 3 quarters · filed 2018-02-28 | $28.10M derived: sum of 4 quarters · filed 2018-02-28 | ||
| 2016-03-31 | $7.70M 10-Q · filed 2017-04-28 | $15.10M derived: sum of 2 quarters · filed 2018-02-28 | $20.60M derived: sum of 3 quarters · filed 2018-02-28 | $26.90M derived: sum of 4 quarters · filed 2018-02-28 | ||
| 2015-12-31 | $7.40M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $12.90M derived: sum of 2 quarters · filed 2018-02-28 | $19.20M derived: sum of 3 quarters · filed 2018-02-28 | $28.10M 10-K · filed 2018-02-28 | ||
| 2015-09-30 | $5.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | $11.80M derived: sum of 2 quarters · filed 2016-10-28 | $20.70M 10-Q · filed 2016-10-28 | $25.10M derived: sum of 4 quarters · filed 2017-09-19 | ||
| 2015-06-30 | $6.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-29 | $15.20M 10-Q · filed 2016-07-29 | $19.60M derived: sum of 3 quarters · filed 2017-09-19 | $21.20M derived: sum of 4 quarters · filed 2017-09-19 | ||
| 2015-03-31 | $8.90M 10-Q · filed 2016-04-28 | $13.30M derived: sum of 2 quarters · filed 2017-09-19 | $14.90M derived: sum of 3 quarters · filed 2017-09-19 | $18.90M derived: sum of 4 quarters · filed 2017-09-19 | ||
| 2014-12-31 | $4.40M derived: 8-K 12 month − 10-Q 9 month · filed 2017-09-19 | $6.00M derived: sum of 2 quarters · filed 2017-09-19 | $10.00M derived: sum of 3 quarters · filed 2017-09-19 | $17.00M 8-K · filed 2017-09-19 | ||
| 2014-09-30 | $1.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | $5.60M derived: sum of 2 quarters · filed 2015-10-29 | $12.60M 10-Q · filed 2015-10-29 | $18.30M derived: sum of 4 quarters · filed 2016-02-25 | ||
| 2014-06-30 | $4.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | $11.00M 10-Q · filed 2015-07-30 | $16.70M derived: sum of 3 quarters · filed 2016-02-25 | $20.40M derived: sum of 4 quarters · filed 2016-02-25 | ||
| 2014-03-31 | $7.00M 10-Q · filed 2015-05-01 | $12.70M derived: sum of 2 quarters · filed 2016-02-25 | $16.40M derived: sum of 3 quarters · filed 2016-02-25 | |||
| 2013-12-31 | $5.70M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $9.40M derived: sum of 2 quarters · filed 2016-02-25 | $21.30M 10-K · filed 2016-02-25 | |||
| 2013-09-30 | $3.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-28 | $15.60M 10-Q · filed 2014-10-28 | ||||
| 2013-06-30 | $11.90M 10-Q · filed 2014-07-29 | |||||
| 2012-12-31 | $18.90M 10-K · filed 2015-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pediatrix Medical Group, Inc. (MD) | United States | $2.084B | 11.76 |